Advertisement

Classification of Drug Delivery Systems

  • Hamid Reza Rezaie
  • Mohammadhossein Esnaashary
  • Abolfazl Aref arjmand
  • Andreas Öchsner
Chapter
Part of the SpringerBriefs in Applied Sciences and Technology book series (BRIEFSAPPLSCIENCES)

Abstract

As stated in the last chapter, a drug delivery system is responsible to influence and determine the concentration profile of a drug, the kinetics of drug release, the site, and duration of drug action, and finally prevent the unwelcome side effects of a drug.

References

  1. 1.
    Perrie Y, Rades T (2009) Pharmaceutics: drug delivery and targeting, 1st edn. Pharmaceutical PressGoogle Scholar
  2. 2.
    Jain N, Valli K, Vk Devi (2010) Importance of novel drug delivery systems in herbal medicines. Pharmacogn Rev 4:27.  https://doi.org/10.4103/0973-7847.65322CrossRefGoogle Scholar
  3. 3.
    Jain KK (2008) Drug delivery systems—an overview. In: Jain KK (ed) Drug delivery systems. Humana Press, pp 1–50CrossRefGoogle Scholar
  4. 4.
    Das D, Pal S (2015) Modified biopolymer-dextrin based crosslinked hydrogels: application in controlled drug delivery. RSC Adv 5:25014–25050.  https://doi.org/10.1039/C4RA16103CCrossRefGoogle Scholar
  5. 5.
    Webster John G (2006) Encyclopedia of medical devices and instrumentation, 2nd edn. Wiley, Hoboken, NJ, USACrossRefGoogle Scholar
  6. 6.
    Agrawal S, Giri TK, Tripathi DK, Alexander AA (2012) A review on novel therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based self micro emulsifying drug delivery system: a novel approach. Am J Drug Discov Dev 2:143–183.  https://doi.org/10.3923/ajdd.2012.143.183
  7. 7.
    Anselmo AC, Mitragotri S (2014) An overview of clinical and commercial impact of drug delivery systems. J Control Release 190:15–28.  https://doi.org/10.1016/j.jconrel.2014.03.053CrossRefGoogle Scholar
  8. 8.
    Jain KK (2014) Current status and future prospects of drug delivery systems. In: Jain KK (ed) Drug delivery system. Humana Press, New York, NY, pp 1–56CrossRefGoogle Scholar
  9. 9.
    Langer RS, Peppas NA (1981) Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201–214.  https://doi.org/10.1016/0142-9612(81)90059-4CrossRefGoogle Scholar
  10. 10.
    Coelho JF, Ferreira PC, Alves P, Cordeiro R, Fonseca AC, Góis JR, Gil MH (2010) Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J 1:164–209.  https://doi.org/10.1007/s13167-010-0001-xCrossRefGoogle Scholar
  11. 11.
    Chien Y e W (1991) Novel drug delivery systems, 2nd edn. CRC Press, Boca Raton, FloridaGoogle Scholar
  12. 12.
    Chien YW, Lin S (2007) Drug delivery: controlled release. Encycl Pharm Technol 1082–1103Google Scholar
  13. 13.
    Chien YW, Lin S (2002) Optimisation of treatment by applying programmable rate-controlled drug delivery technology. Clin Pharmacokinet 41:1267–1299.  https://doi.org/10.2165/00003088-200241150-00003CrossRefGoogle Scholar
  14. 14.
    Heller J (1993) Modulated release from drug delivery devices. Crit Rev Ther Drug Carrier Syst 10:253–305Google Scholar
  15. 15.
    Hillery AM, Park K (2017) Drug delivery: fundamentals & applications, 2nd edn. CRC PressGoogle Scholar
  16. 16.
    Keraliya RA, Patel C, Patel P, Keraliya V, Soni TG, Patel RC, Patel MM (2012) Osmotic drug delivery system as a part of modified release dosage form. ISRN Pharm 2012:1–9.  https://doi.org/10.5402/2012/528079CrossRefGoogle Scholar
  17. 17.
    Verma RK, Mishra B, Garg S (2000) Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 26:695–708.  https://doi.org/10.1081/DDC-100101287CrossRefGoogle Scholar
  18. 18.
    Djupesland PG (2013) Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res 3:42–62.  https://doi.org/10.1007/s13346-012-0108-9CrossRefGoogle Scholar
  19. 19.
    Lelawongs P, Jue-Chen L, Siddiqui O, Chien YW (1989) Transdermal iontophoretic delivery of arginine-vasopressin (I): physicochemical considerations. Int J Pharm 56:13–22.  https://doi.org/10.1016/0378-5173(89)90055-0CrossRefGoogle Scholar
  20. 20.
    Maderuelo C, Zarzuelo A, Lanao JM (2011) Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release 154:2–19.  https://doi.org/10.1016/j.jconrel.2011.04.002CrossRefGoogle Scholar
  21. 21.
    Sood N, Bhardwaj A, Mehta S, Mehta A (2014) Stimuli-responsive hydrogels in drug delivery and tissue engineering. Drug Deliv 23:1–23.  https://doi.org/10.3109/10717544.2014.940091CrossRefGoogle Scholar
  22. 22.
    Kumar A, Nautiyal U, Kaur C, Goel V, Piarchand N (2017) Targeted drug delivery system: current and novel approach. 5:448–454Google Scholar
  23. 23.
    Bae YH, Park K (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198–205.  https://doi.org/10.1016/j.jconrel.2011.06.001CrossRefGoogle Scholar
  24. 24.
    Desai PP, Date AA, Patravale VB (2012) Overcoming poor oral bioavailability using nanoparticle formulations—opportunities and limitations. Drug Discov Today Technol 9:e87–e95.  https://doi.org/10.1016/j.ddtec.2011.12.001CrossRefGoogle Scholar
  25. 25.
    Smart JD (2005) Buccal drug delivery. Expert Opin Drug Deliv 2:507–517.  https://doi.org/10.1517/17425247.2.3.507CrossRefGoogle Scholar
  26. 26.
    Hao J, Heng PWS (2003) Buccal delivery systems. Drug Dev Ind Pharm 29:821–832.  https://doi.org/10.1081/DDC-120024178CrossRefGoogle Scholar
  27. 27.
    Jannin V, Lemagnen G, Gueroult P, Larrouture D, Tuleu C (2014) Rectal route in the 21st century to treat children. Adv Drug Deliv Rev 73:34–49.  https://doi.org/10.1016/j.addr.2014.05.012CrossRefGoogle Scholar
  28. 28.
    Dychter SS, Gold DA, Haller MF (2012) Subcutaneous drug delivery. J Infus Nurs 35:154–160.  https://doi.org/10.1097/NAN.0b013e31824d2271CrossRefGoogle Scholar
  29. 29.
    Doyle GR, McCutcheon AJ (2012) Clinical procedures for safer patient care. British Columbia Institute of Technology (BCIT)Google Scholar
  30. 30.
    Ard GHW (1998) Formulation-related problems associated with intravenous drug delivery. J Pharm Sci 87:787–796.  https://doi.org/10.1021/js980051iCrossRefGoogle Scholar
  31. 31.
    Wallace SJ, Li J, Nation RL, Boyd BJ (2012) Drug release from nanomedicines: selection of appropriate encapsulation and release methodology. Drug Deliv Transl Res 2:284–292.  https://doi.org/10.1007/s13346-012-0064-4CrossRefGoogle Scholar
  32. 32.
    Kita K, Dittrich C (2011) Drug delivery vehicles with improved encapsulation efficiency: taking advantage of specific drug-carrier interactions. Expert Opin Drug Deliv 8:329–342.  https://doi.org/10.1517/17425247.2011.553216CrossRefGoogle Scholar
  33. 33.
    Parent M, Baradari H, Champion E, Damia C, Viana-Trecant M (2017) Design of calcium phosphate ceramics for drug delivery applications in bone diseases: a review of the parameters affecting the loading and release of the therapeutic substance. J Control Release 252:1–17.  https://doi.org/10.1016/j.jconrel.2017.02.012CrossRefGoogle Scholar
  34. 34.
    Pond SM, Tozer TN (1984) First-pass elimination. Clin Pharmacokinet 9:1–25.  https://doi.org/10.2165/00003088-198409010-00001CrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Hamid Reza Rezaie
    • 1
  • Mohammadhossein Esnaashary
    • 1
  • Abolfazl Aref arjmand
    • 1
  • Andreas Öchsner
    • 2
  1. 1.Department of Engineering Materials, Ceramic and Biomaterial DivisionIran University of Science and TechnologyTehranIran
  2. 2.Faculty of Mechanical EngineeringEsslingen University of Applied SciencesEsslingenGermany

Personalised recommendations